176 related articles for article (PubMed ID: 20717116)
1. Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.
Elsberger B; Fullerton R; Zino S; Jordan F; Mitchell TJ; Brunton VG; Mallon EA; Shiels PG; Edwards J
Br J Cancer; 2010 Sep; 103(6):899-909. PubMed ID: 20717116
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of Src family members in renal clear cell carcinoma.
Qayyum T; McArdle PA; Lamb GW; Jordan F; Orange C; Seywright M; Horgan PG; Jones RJ; Oades G; Aitchison MA; Edwards J
Br J Cancer; 2012 Aug; 107(5):856-63. PubMed ID: 22814579
[TBL] [Abstract][Full Text] [Related]
3. Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment.
Elsberger B; Paravasthu DM; Tovey SM; Edwards J
J Cancer Res Clin Oncol; 2012 Feb; 138(2):327-32. PubMed ID: 22134837
[TBL] [Abstract][Full Text] [Related]
4. Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?
Elsberger B; Tan BA; Mitchell TJ; Brown SB; Mallon EA; Tovey SM; Cooke TG; Brunton VG; Edwards J
Am J Pathol; 2009 Oct; 175(4):1389-97. PubMed ID: 19762712
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
Roseweir AK; Qayyum T; Lim Z; Hammond R; MacDonald AI; Fraser S; Oades GM; Aitchison M; Jones RJ; Edwards J
BMC Cancer; 2016 Mar; 16():229. PubMed ID: 26984511
[TBL] [Abstract][Full Text] [Related]
6. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
[TBL] [Abstract][Full Text] [Related]
7. Expression and muscarinic receptor coupling of Lyn kinase in cultured human airway smooth muscle cells.
Pertel T; Zhu D; Panettieri RA; Yamaguchi N; Emala CW; Hirshman CA
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L492-500. PubMed ID: 16227319
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
9. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury.
Tsuda M; Tozaki-Saitoh H; Masuda T; Toyomitsu E; Tezuka T; Yamamoto T; Inoue K
Glia; 2008 Jan; 56(1):50-8. PubMed ID: 17918263
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
11. Integrated signaling and transcriptome analysis reveals Src family kinase individualities and novel pathways controlled by their constitutive activity.
Koutras N; Morfos V; Konnaris K; Kouvela A; Shaukat AN; Stathopoulos C; Stamatopoulou V; Nika K
Front Immunol; 2023; 14():1224520. PubMed ID: 37680627
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer.
Campbell EJ; McDuff E; Tatarov O; Tovey S; Brunton V; Cooke TG; Edwards J
Br J Cancer; 2008 Dec; 99(11):1769-74. PubMed ID: 19018258
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
Trible RP; Emert-Sedlak L; Smithgall TE
J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
[TBL] [Abstract][Full Text] [Related]
14. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
16. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.
Stettner MR; Wang W; Nabors LB; Bharara S; Flynn DC; Grammer JR; Gillespie GY; Gladson CL
Cancer Res; 2005 Jul; 65(13):5535-43. PubMed ID: 15994925
[TBL] [Abstract][Full Text] [Related]
17. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
[TBL] [Abstract][Full Text] [Related]
18. Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival.
Elsberger B; Tan BA; Mallon EA; Brunton VG; Edwards J
Br J Cancer; 2010 Dec; 103(12):1831-4. PubMed ID: 21063412
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny.
Longo NS; Wang X; Wildin RS; Abraham KM
Mol Immunol; 1999; 36(15-16):979-92. PubMed ID: 10698302
[TBL] [Abstract][Full Text] [Related]
20. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
